Aeolus Pharmaceuticals, Inc.
AOLS · OTC
6/30/2017 | 3/31/2017 | 12/31/2016 | 9/30/2016 | |
|---|---|---|---|---|
| Market Cap | $13,812 | $14,448 | $28,896 | $28,901 |
| - Cash | $403 | $981 | $1,895 | $3,155 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $13,409 | $13,467 | $27,001 | $25,746 |
| Revenue | $13 | $129 | $83 | $546 |
| % Growth | -89.9% | 55.4% | -84.8% | – |
| Gross Profit | -$412 | -$465 | -$406 | -$438 |
| % Margin | -3,169.2% | -360.5% | -489.2% | -80.2% |
| EBITDA | -$949 | -$1,035 | -$1,087 | -$1,023 |
| % Margin | -7,300% | -802.3% | -1,309.6% | -187.4% |
| Net Income | -$949 | -$1,035 | -$1,087 | -$1,023 |
| % Margin | -7,300% | -802.3% | -1,309.6% | -187.4% |
| EPS Diluted | -0.006 | -0.007 | -0.007 | -0.007 |
| % Growth | 8.8% | 4.2% | -6% | – |
| Operating Cash Flow | -$578 | -$914 | -$1,260 | -$601 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$578 | -$914 | -$1,260 | -$601 |